Baxter Hlthcare Drug Patent Portfolio
Baxter Hlthcare owns 5 orange book drugs protected by 8 US patents with Nexterone having the least patent protection, holding only 2 patents. And Brevibloc In Plastic Container with maximum patent protection, holding 4 patents. Given below is the list of Baxter Hlthcare's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7635773 | Sulfoalkyl ether cyclodextrin compositions | 13 Mar, 2029 | Active |
| US6869939 | Formulations containing amiodarone and sulfoalkyl ether cyclodextrin | 04 May, 2022 | Expired |
| US6310094 | Ready-to-use esmolol solution | 12 Jul, 2021 | Expired |
| US6528540 | Esmolol formulation | 12 Jul, 2021 | Expired |
| US6310094 | Ready-to-use esmolol solution | 12 Jan, 2021 | Expired |
| US6528540 | Esmolol formulation | 12 Jan, 2021 | Expired |
| US5617906 | Container for anaesthetic agent | 08 Oct, 2014 | Expired |
| US5617906 | Container for anaesthetic agent | 08 Apr, 2014 | Expired |
Latest Legal Activities on Baxter Hlthcare's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Baxter Hlthcare.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Correspondence Address Change
Critical
| 04 Dec, 2022 | US7635773 |
|
Correspondence Address Change
Critical
| 04 Dec, 2022 | US6869939 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 09 Jun, 2021 | US7635773 |
| File Marked Found | 07 Aug, 2018 | US6310094 |
| File Marked Found | 07 Aug, 2018 | US6310094 |
| File Marked Found | 07 Aug, 2018 | US6310094 |
| Entity Status Set To Undiscounted (Initial Default Setting or Status Change) | 09 Jun, 2016 | US6869939 |
| Termination or Final Written Decision | 27 Apr, 2016 | US6528540 |
| Termination or Final Written Decision | 27 Apr, 2016 | US6310094 |
| Termination or Final Written Decision | 27 Apr, 2016 | US6528540 |
| Termination or Final Written Decision | 27 Apr, 2016 | US6528540 |
| Termination or Final Written Decision | 27 Apr, 2016 | US6310094 |
| Termination or Final Written Decision | 27 Apr, 2016 | US6310094 |
| Petition Requesting Trial | 19 Nov, 2015 | US6310094 |
| Petition Requesting Trial | 19 Nov, 2015 | US6528540 |
Baxter Hlthcare's Drug Patent Litigations
Baxter Hlthcare's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on Nov 19, 2015, against patent number US6528540. The petitioner Mylan Pharmaceuticals Inc., challenged the validity of this patent, with Baxter International Inc. as the respondent. Click below to track the latest information on how companies are challenging Baxter Hlthcare's patents.
| Patent | Proceeding Filing Date | Status | Respondent | Petitioner |
|---|---|---|---|---|
 | ||||
| US6310094 | November, 2015 |
Terminated-Denied
(27 Apr, 2016)
| Baxter International Inc. | Mylan Pharmaceuticals Inc. |
| US6528540 | November, 2015 |
Terminated-Denied
(27 Apr, 2016)
| Baxter International Inc. | Mylan Pharmaceuticals Inc. |
Baxter Hlthcare's Family Patents
Baxter Hlthcare Drug List
Given below is the complete list of Baxter Hlthcare's drugs and the patents protecting them.
1. Brevibloc
Brevibloc is protected by 4 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6310094
(Pediatric)
| Ready-to-use esmolol solution |
12 Jul, 2021
(3 years ago)
| Expired |
| US6528540
(Pediatric)
| Esmolol formulation |
12 Jul, 2021
(3 years ago)
| Expired |
| US6310094 | Ready-to-use esmolol solution |
12 Jan, 2021
(4 years ago)
| Expired |
| US6528540 | Esmolol formulation |
12 Jan, 2021
(4 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Brevibloc's drug page
2. Brevibloc Double Strength In Plastic Container
Brevibloc Double Strength In Plastic Container is protected by 4 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6310094
(Pediatric)
| Ready-to-use esmolol solution |
12 Jul, 2021
(3 years ago)
| Expired |
| US6528540
(Pediatric)
| Esmolol formulation |
12 Jul, 2021
(3 years ago)
| Expired |
| US6310094 | Ready-to-use esmolol solution |
12 Jan, 2021
(4 years ago)
| Expired |
| US6528540 | Esmolol formulation |
12 Jan, 2021
(4 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Brevibloc Double Strength In Plastic Container's drug page
3. Brevibloc In Plastic Container
Brevibloc In Plastic Container is protected by 4 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6310094
(Pediatric)
| Ready-to-use esmolol solution |
12 Jul, 2021
(3 years ago)
| Expired |
| US6528540
(Pediatric)
| Esmolol formulation |
12 Jul, 2021
(3 years ago)
| Expired |
| US6310094 | Ready-to-use esmolol solution |
12 Jan, 2021
(4 years ago)
| Expired |
| US6528540 | Esmolol formulation |
12 Jan, 2021
(4 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Brevibloc In Plastic Container's drug page
4. Nexterone
Nexterone is protected by 2 patents, out of which 1 has expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7635773 | Sulfoalkyl ether cyclodextrin compositions |
13 Mar, 2029
(3 years from now)
| Active |
| US6869939 | Formulations containing amiodarone and sulfoalkyl ether cyclodextrin |
04 May, 2022
(3 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Nexterone's drug page
5. Suprane
Suprane is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5617906
(Pediatric)
| Container for anaesthetic agent |
08 Oct, 2014
(10 years ago)
| Expired |
| US5617906 | Container for anaesthetic agent |
08 Apr, 2014
(11 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Suprane's drug page